| Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms (NCT03878199) | Ohio State University Comprehensive Cancer Center | 2019-02-20 |
| A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2) (NCT03773666) | Dana-Farber Cancer Institute | 2019-02-20 |
| An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection (NCT02972450) | ANRS, Emerging Infectious Diseases | 2019-02-20 |
| A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease (NCT03681067) | University of Birmingham | 2019-02-20 |
| First in Human Study of NG-350A (an Oncolytic Adenoviral Vector Which Expresses an Anti-CD40 Antibody) (NCT03852511) | Akamis Bio | 2019-02-19 |
| Study to Determine the Effect of Food on the Blood Levels of AST2818 Following Single Oral Doses in Healthy Male Volunteers (NCT03926182) | Allist Pharmaceuticals, Inc. | 2019-02-19 |
| Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults (NCT03849495) | Chong Kun Dang Pharmaceutical | 2019-02-19 |
| A Study of Anti-PD1 Antibody-activated TILs in Non-small Cell Lung Cancer (NCT03903887) | Sun Yat-sen University | 2019-02-19 |
| Andes Virus DNA Vaccine for the Prevention of Hantavirus Pulmonary Syndrome Using the PharmaJet Stratis(R) Needle-Free Injection Delivery Device (NCT03682107) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-02-19 |
| Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) (NCT03769467) | Atara Biotherapeutics | 2019-02-19 |
| A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and Lymphomas (NCT03763149) | Innovent Biologics (Suzhou) Co. Ltd. | 2019-02-19 |
| Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma (NCT03721068) | UNC Lineberger Comprehensive Cancer Center | 2019-02-19 |
| A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer (NCT03904537) | Sun Yat-sen University | 2019-02-19 |
| A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4 (NCT03844191) | CeleCor Therapeutics | 2019-02-18 |
| CLN-0046: Treatment of AMD Subjects With OTX-TKI (NCT03630315) | Ocular Therapeutix, Inc. | 2019-02-18 |
| A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers (NCT04426708) | Hua Medicine Limited | 2019-02-18 |
| Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9 (NCT03744026) | CarThera | 2019-02-18 |
| Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in Children With MDR-TB With and Without HIV (NCT03141060) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-02-18 |
| Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa (NCT03529877) | RHEACELL GmbH & Co. KG | 2019-02-16 |
| FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors (NCT03841110) | Fate Therapeutics | 2019-02-15 |
| MPN-RC 118 AVID200 in Myelofibrosis (NCT03895112) | John Mascarenhas | 2019-02-15 |
| Effect of Behavioral Therapy Versus Interferential Current on Bladder Dysfunction in Patients With Multiple Sclerosis (NCT04635709) | Taibah University | 2019-02-15 |
| A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355 (NCT03802162) | Chong Kun Dang Pharmaceutical | 2019-02-15 |
| CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease (NCT03605927) | H. Lee Moffitt Cancer Center and Research Institute | 2019-02-15 |
| A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity (NCT03842202) | Novo Nordisk A/S | 2019-02-15 |
| Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid Tumors (NCT04088604) | Luye Pharma Group Ltd. | 2019-02-15 |
| Evaluation of the PK Profile of Firibastat Following Administration of Firibastat Prototype Tablet Formulations (NCT03714685) | Quantum Genomics SA | 2019-02-15 |
| Central Glutathione Levels in Women With Late Life Depression: a Cross Sectional Pilot Feasibility Study (NCT02757833) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2019-02-15 |
| Single and Multiple Ascending Dose Study of JW1601 for Healthy Volunteers (NCT04018170) | JW Pharmaceutical | 2019-02-15 |
| Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses (NCT03752307) | University of New Mexico | 2019-02-15 |
| A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes (NCT03746041) | University of Rochester | 2019-02-14 |
| A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers (NCT03843775) | Memorial Sloan Kettering Cancer Center | 2019-02-14 |
| IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo (NCT04190693) | Imcyse SA | 2019-02-14 |
| ImmunoPET With an Anti-CD8 Imaging Agent (NCT04029181) | University Medical Center Groningen | 2019-02-14 |
| A Study in Healthy Subjects to Investigate Whether Administration of Lucerastat Can Affect Normal Heart Function (NCT03832452) | Idorsia Pharmaceuticals Ltd. | 2019-02-14 |
| Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c (NCT04488107) | Ahon Pharmaceutical Co., Ltd. | 2019-02-14 |
| PDR001 Plus Imatinib for Metastatic or Unresectable GIST (NCT03609424) | Asan Medical Center | 2019-02-14 |
| Renaparin® in Kidney Transplantation (NCT03773211) | Corline Biomedical AB | 2019-02-14 |
| Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors (NCT03932565) | The Sixth Affiliated Hospital of Wenzhou Medical University | 2019-02-13 |
| Sudapyridine (WX-081) in Healthy Volunteers (NCT06117514) | Shanghai Jiatan Pharmatech Co., Ltd | 2019-02-13 |
| Evaluate the Pharmacokinetics of CC-220 in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared With Healthy Subjects (NCT03824678) | Celgene | 2019-02-13 |
| Rivaroxaban Hypericum Trial (NCT03796377) | Insel Gruppe AG, University Hospital Bern | 2019-02-13 |
| A Study to Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-BM-BLD in Pediatric Patients With Pearson Syndrome (NCT03384420) | Minovia Therapeutics Ltd. | 2019-02-13 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects (NCT03830125) | Bridge Biotherapeutics, Inc. | 2019-02-13 |
| IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors (NCT03758781) | H. Lee Moffitt Cancer Center and Research Institute | 2019-02-13 |
| Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream (NCT03899064) | MC2 Therapeutics | 2019-02-13 |
| First in Human Study of IBI101 in Chinese Subjects With Advanced Solid Tumors (NCT03758001) | Innovent Biologics (Suzhou) Co. Ltd. | 2019-02-13 |
| Treatment of Chronic Itch in Patients Under Arsenic Exposure With Naloxone (NCT03751111) | Xiangya Hospital of Central South University | 2019-02-13 |
| Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides (NCT03635879) | Cerecin | 2019-02-13 |
| A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer (NCT03803761) | National Cancer Institute (NCI) | 2019-02-13 |
| A Study of a Personalized Neoantigen Cancer Vaccine (NCT03639714) | Gritstone bio, Inc. | 2019-02-13 |
| A Study of SHR-A1403 in Patients With Advanced Solid Tumor (NCT03856541) | Jiangsu HengRui Medicine Co., Ltd. | 2019-02-13 |
| Study to Evaluate DNL747 in Subjects With Alzheimer's Disease (NCT03757325) | Denali Therapeutics Inc. | 2019-02-13 |
| A Study to Assess the Drug-Drug Interaction Between Bedaquiline and Clarithromycin in Healthy Adult Participants (NCT03800550) | Janssen Research & Development, LLC | 2019-02-13 |
| Safety, Tolerability, Pharmacokinetics, and Food Effect of BLU-782 in Healthy Adults (NCT03858075) | Blueprint Medicines Corporation | 2019-02-12 |
| to Assess the Safety of Ga68-Dolacga Injection in Healthy Volunteers (NCT03908957) | National Atomic Research Institute, Taiwan | 2019-02-12 |
| A Study of Selpercatinib (LY3527723) in Healthy Participants (NCT05338515) | Eli Lilly and Company | 2019-02-12 |
| MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma (NCT03896568) | M.D. Anderson Cancer Center | 2019-02-12 |
| Study to Assess PK, Safety and Tolerability in Patients With DM and CKD (NCT03795389) | DiaMedica Therapeutics Inc | 2019-02-12 |
| PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (NCT03817320) | Therapeutic Advances in Childhood Leukemia Consortium | 2019-02-12 |
| Concurrent Neoadjuvant Chemoradiotherapy Plus Durvalumab (MEDI4736) in Resectable Stage III NSCLC (NCT03694236) | Yonsei University | 2019-02-12 |
| Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons (NCT03803605) | University of North Carolina, Chapel Hill | 2019-02-12 |
| Pharmacokinetic Study of Stiripentol and Its Metabolites After Multiple Dose Oral Administration in Healthy Male Volunteers (NCT03866928) | Biocodex | 2019-02-12 |
| A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib on Metformin (NCT03826602) | Seagen Inc. | 2019-02-12 |
| A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype. (NCT03910660) | BioXcel Therapeutics Inc | 2019-02-12 |
| A Single and Multiple Doses Safety, Tolerability, Pharmacokinetics and Food Effect Study of KVD824 in Healthy Volunteers (NCT05178355) | KalVista Pharmaceuticals, Ltd. | 2019-02-12 |
| Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer (NCT03847519) | Advaxis, Inc. | 2019-02-12 |
| P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular Carcinoma (NCT04233840) | National Taiwan University Hospital | 2019-02-12 |
| A Study to Evaluate Central Nervous System (CNS) Pharmacodynamic Activity of TAK-653 in Healthy Participants Using Transcranial Magnetic Stimulation (TMS) (NCT03792672) | Neurocrine Biosciences | 2019-02-11 |
| Blocking Mifepristone Action With Progesterone (NCT03774745) | University of California, Davis | 2019-02-11 |
| Study to Evaluate the Effect of GSK3640254 on the Pharmacokinetics of Tenofovir Alafenamide/Emtricitabine (NCT03836729) | ViiV Healthcare | 2019-02-11 |
| A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies (NCT03886831) | Prelude Therapeutics | 2019-02-11 |
| Phase 1b/2a, Open-label Study of Vactosertib in Combination With Durvalumab in Advanced NSCLC (NCT03732274) | MedPacto, Inc. | 2019-02-11 |
| Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers (NCT03864666) | Genovate Biotechnology Co., Ltd., | 2019-02-11 |
| Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer (NCT03754933) | GeoVax, Inc. | 2019-02-11 |
| A Study in Healthy People to Test if Taking Different Formulations of BI 425809 Tablets Influences the Amount of BI 425809 in the Blood (NCT03817476) | Boehringer Ingelheim | 2019-02-11 |
| Itacitinib + Everolimus in Hodgkin Lymphoma (NCT03697408) | University of Pennsylvania | 2019-02-11 |
| A Study of MK-8527 in Human Immunodeficiency Type 1 Virus (HIV-1) Infected Participants (MK-8527-002) (NCT03615183) | Merck Sharp & Dohme LLC | 2019-02-11 |
| First in Human Study of ChAdOx1-HBV in Healthy Participants and Participants With Chronic hepB Infection (NCT04297917) | Barinthus Biotherapeutics | 2019-02-10 |
| Effect of Glucose on QTc Interval in Type 1 Diabetes (NCT01984827) | Richmond Research Institute | 2019-02-10 |
| Study to Evaluate the Effects of 90 mg Intravenous Infusions of GC4419 on the Single Dose Pharmacokinetics of Dextromethorphan in Healthy Adult Subjects (NCT03792971) | Galera Therapeutics, Inc. | 2019-02-10 |
| How Successful is Supplemental Intraseptal Anaesthesia in Patients With Mandibular Teeth Extraction or Irreversible Pulpitis (NCT03880409) | Taibah University | 2019-02-09 |
| Pilot-Tart Cherry, Mitral Transcriptome, and POAF Incidence (NCT03793465) | University of Michigan | 2019-02-08 |
| Safety and Preliminary Efficacy of IVMED-80 Eye Drops in Keratoconus Patients (NCT05241145) | iVeena Delivery Systems, Inc. | 2019-02-08 |
| Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Patients With Recurrent Posterior Fossa Ependymoma (NCT03572530) | The University of Texas Health Science Center, Houston | 2019-02-08 |
| Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults (NCT03828149) | Novus Therapeutics, Inc | 2019-02-08 |
| Livionex on Reducing Plaque Accumulation and Improving Oral Health in Children (NCT04368533) | University of California, San Francisco | 2019-02-08 |
| A Study of INO-A002 in Healthy Dengue Virus-naive Adults (NCT03831503) | University of Pennsylvania | 2019-02-07 |
| Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut Syndrome (NCT03731715) | SK Life Science, Inc. | 2019-02-07 |
| A DRUG-DRUG INTERACTION STUDY BETWEEN PF-06650833 AND PF-06651600 FOLLOWING MULTIPLE DOSES IN HEALTHY PARTICIPANTS (NCT03827668) | Pfizer | 2019-02-07 |
| Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases (NCT03824327) | Ohio State University Comprehensive Cancer Center | 2019-02-07 |
| A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fed State (NCT03944200) | Dong-A ST Co., Ltd. | 2019-02-07 |
| A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting State (NCT03939143) | Dong-A ST Co., Ltd. | 2019-02-07 |
| Regorafenib Combined With Irinotecan as Second-line in Patients With Metastatic Gastro-oesophageal Adenocarcinomas (NCT03722108) | UNICANCER | 2019-02-07 |
| A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation (NCT03513939) | Sernova Biotherapeutics Inc. | 2019-02-07 |
| Study to Investigate the Effect of Balovaptan on the QTC Interval in Healthy Subjects (NCT03808298) | Hoffmann-La Roche | 2019-02-07 |
| A Pharmacokinetic Study of Tedizolid Phosphate in Pediatric Participants With Gram-Positive Infections (MK-1986-014) (NCT03217565) | Merck Sharp & Dohme LLC | 2019-02-06 |
| Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO (NCT02851472) | New York Medical College | 2019-02-06 |
| Evaluation of the Efficiacy of Mecobalamine in the Treatment of Long-term Pain in Women Diagnosed With Fibromyalgia (NCT05008042) | Linnaeus University | 2019-02-06 |
| Pharmacokinetics and Metabolism of (14C)-Labelled PXL770 (NCT03886103) | Poxel SA | 2019-02-06 |